EFFECT OF REPETITIVE HIGH-DOSE TREATMENT WITH SOLUBLE COMPLEMENT RECEPTOR TYPE 1 AND COBRA VENOM FACTOR ON DISCORDANT XENOGRAFT SURVIVAL1,2

Daniel Candinas(University Hospital of Bern), Fritz H. Bach(Beth Israel Deaconess Medical Center), Simon C. Robson(Beth Israel Deaconess Medical Center), Wayne W. Hancock(Children's Hospital of Philadelphia), Una Ryan(Murdoch University), Susanne M. Scesney(Cell Medica (Switzerland)), Henry C. Marsh(One Cell Systems (United States)), Agustin P. Dalmasso(Veterans Health Administration), Beth‐Ann Lesnikoski(Beth Israel Deaconess Medical Center), T Miyatake(Deaconess Hospital)
Transplantation
August 1, 1996
Cited by 59


Related Papers